Lab orders, panels and clinical testing

Where you are

Laboratory coding starts with a clinical question and a performed test. An order requests work. A specimen supplies material. An instrument performs a method. A result answers a question. These are related facts, but they are not interchangeable billing units.

By the end of this lesson, you should be able to compare an order with the test record, recognize a complete panel, distinguish a necessary repeat from a quality check and identify the certificate and modifier questions for an office laboratory.

Read the order and the reason

For Medicare diagnostic laboratory services, identify the treating physician or qualified practitioner who ordered the test and the reason it was needed. Keep the order, the evidence of the patient's condition and the record showing that the laboratory processed the test. The entity submitting the claim must retain supporting documentation. [lab-orders-cms]

An unsigned requisition does not automatically mean that no valid order exists. CMS permits an authenticated medical record to establish the treating practitioner's intent when the order itself lacks a signature. A telephone order also needs the required documentation. Do not manufacture a signature or add an unsupported diagnosis to repair a missing record. [lab-orders-cms]

Original fictional example: a requisition says “chemistry testing,” but the completed laboratory record lists a specific panel. Ask whether the order and authenticated clinical record support those tests. The instrument's ability to run them is not evidence that the practitioner requested them.

Build a test worksheet

Record the service date, specimen source, requested test, completed method, result and billing laboratory. Add the clinical reason, repeat-test reason and any referral to another laboratory. Then compare that worksheet with the current complete code entry.

For urinalysis, note whether the method was automated and whether microscopy occurred. A urine culture answers a different question from a chemical strip examination. Do not infer one from the other or count every constituent on a strip as a separately performed procedure. NCCI defines an analyte broadly and does not equate several outputs from one procedure with several billable procedures. [ncci-laboratory-2026, A,N.2]

For coagulation testing, identify the actual assay and the ordered clinical purpose. A specimen described only as “blood” does not tell you whether a chemistry, cell-count or coagulation procedure occurred. Use the laboratory report rather than guessing from the diagnosis.

A complete panel has defined components

Open the current organ- or disease-oriented panel entry and compare every required component with the completed tests. Under NCCI, when all tests of the defined panel are performed, use the panel rather than separately reporting its included tests. Individually written orders do not necessarily change that relationship. [ncci-laboratory-2026, C]

Do not call an incomplete group a complete panel merely because the order used the panel's name. Conversely, do not break a complete panel into its components because the component charges total more. The performed tests and the full entry control the comparison.

Original fictional worksheet: the order lists the component tests separately, and the final report confirms every required component of one defined panel. Your first task is to recognize that complete panel. A separate medically necessary test outside it needs its own review; it does not erase the panel relationship.

Repeats need a clinical reason

A second result needed during treatment differs from rerunning a specimen to confirm the first result. NCCI allows review of separately reportable, medically necessary repeat testing. It does not allow extra units merely for confirmation, a specimen problem or equipment trouble. [ncci-laboratory-2026, A,C]

Medicare's clinical laboratory fee schedule instructions use modifier 91 for an applicable repeat laboratory test. The same instruction excludes tests repeated only to verify results and situations where a standard entry already describes the series. Read the applicable modifier and entry before assigning it. [claims-lab-cms, 100.5.1]

Compare two fictional records. In one, a technologist reruns an unexpectedly high result to verify accuracy. In the other, treatment occurs and the practitioner needs a later measurement to assess the response. Only the second establishes the stated clinical reason to review a separately reportable repeat. It still needs a valid order, documentation and the applicable coding instructions.

Calculations are not direct measurements

A chemistry report can contain measured values and calculated values. NCCI specifically prohibits reporting a calculated LDL cholesterol value as a direct LDL measurement. The presence of a number on the report does not establish the method represented by that procedure. [ncci-laboratory-2026, G.1]

For each proposed entry, ask what the laboratory actually did. If the report does not distinguish a calculation from an assay, consult the method record. Do not infer a separately performed measurement from a familiar result label.

Blood-count verification can be included

A laboratory may examine a smear to complete or verify an ordered automated blood count. NCCI does not allow a separate smear examination simply because the laboratory's own criteria triggered that verification. An independently ordered combination has different instructions, so read the order and the exact work. [ncci-laboratory-2026, H.1–2]

The same caution applies to methods that produce the same differential result. Two methods are not automatically two services. Your explanation should identify whether the additional work completes the ordered test or answers a separate, medically necessary question.

Follow-up immunology testing needs support

NCCI distinguishes testing with a crude allergen extract from testing specific components. It permits specified combinations when different allergens are tested or when ordered, necessary component testing follows a positive extract result. It does not authorize routine automatic component testing after every positive extract. [ncci-laboratory-2026, I]

Keep the allergen, method, result, order and treatment purpose together. “Positive” alone is not a complete order for every available follow-up assay.

CLIA and QW answer different questions

CLIA regulates laboratory quality and certificate scope. A certificate of waiver permits tests categorized as waived; it does not authorize every laboratory method. Laboratories must follow the manufacturer's instructions for waived testing. Provider-performed microscopy has its own limited scope. [clia-cms-2026, pages 4–5]

QW identifies waived testing where Medicare requires that modifier. Some waived tests have a unique procedure code and do not require it. Check the actual test system, current categorization, certificate and effective-date instructions. A code number alone is not enough to decide that any method using it is waived. [claims-lab-cms, 70.8–70.9]

Book drill

Find a complete panel, compare it with its components and record the page in your own book. Then compare a urinalysis method with and without microscopy. Finish by explaining a clinical repeat and a quality-control rerun.

Checkpoint

Check your reasoning

The order and performed method must support the entry. A panel includes its defined tests; a result calculation is not a separate direct assay. A necessary later result differs from confirmation work. CLIA certificate scope and QW reporting both need review, but neither replaces medical necessity.

Sources

1. CMS — Medicare NCCI 2026 Chapter X: Pathology and Laboratory. 2026. Accessed 2026-09-10.
2. CMS — CLIA Program and Medicare Laboratory Services. March 2026. Accessed 2026-09-10.
3. CMS — Medicare Claims Processing Manual Chapter 16: Laboratory Services. Current consolidated manual accessed September 2026. Accessed 2026-09-10.
4. CMS — Lab Test Order Requirements. Page modified November 25, 2025. Accessed 2026-09-10.